credentis presents clinical data showing in-depth effect of the carious treatment

The patented Curolox technology of credentis is based on peptides self-assembling into a matrix triggering a biomimetic mineralisation and repair mechanism. The technology is the basis of all credentis’ innovative products.

Curodont Repair provides dentists with a non-invasive option for natural mineralisation rather than classical repair of carious lesions. Applied to an early lesion Curodont Repair forms a scaffold within the lesion around which new hydroxyapatite can form and grow. Ideally, within several weeks the lesion will mineralise. This effect is observed in a growing number of patients both in clinical studies and daily practice settings. Curodont Protect uses the Curolox technology to protect the tooth surface from acid attack or to treat unpleasant tooth sensations.

“The presentation of the clinical data and the verification of the data obtained in the Proof-of-Concept clinical study presents a milestone for credentis, as it shows the in-depth treatment of the tooth decay. credentis seeks to support with its regenerative product line a trend towards prevention and early treatment. Curodont Repair has its potential in the treatment of early dental caries, whereas Curodont Protect has its main benefit in prophylaxis and in the treatment of dentin hypersensitivity!” explains CEO Dominik Lysek. The ultimate goal is to prevent caries by the use of its regenerative product line and frequent dental recalls by dentists and dental hygienists.